19 April 2010
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, will be announcing its results for the first quarter ended 3 April 2010 on Thursday 6 May 2010 at 7am BST/2.00am Eastern time. This will be followed by a conference call with financial analysts at 8.30am BST/3.30am Eastern, which can be heard live via audio webcast on the Smith & Nephew website at www.smith-nephew.com and available on the site archive shortly afterwards.
About Us
Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2009 were nearly $3.8 billion.
Enquiries:
Investors/Analysts |
|
Hannah Longbottom |
Tel: +44 (0) 207 401 7646 |
Corporate Affairs Manager |
|
Smith & Nephew plc |
|
|
|
Media |
|
Jon Coles Brunswick - London |
Tel: +44 (0) 20 7404 5959 |
|
|
Cindy Leggett-Flynn Brunswick - New York |
Tel: +1 (212) 333 3810 |